On November 21-22, a couple of month after the first-ever High-Level Meeting on Universal Health Coverage (UHC) is taking place during the UN General Assembly, POLITICO is bringing the Annual Health Care Summit to Amsterdam — a world-renowned life science innovation center and the new home of the European Medicines Agency — for what will be its fourth successful edition. We’ll gather the industry’s top minds together with key policymakers, scientists, business leaders and patient representatives to debate on the policy and cooperative innovations to better public health for the whole of society.
Join Bayer to discuss how innovative medicines can support societal efforts against Cancer.
By LuCE – Lung Cancer Europe
This edition of report focusses on early diagnosis and screening in lung cancer. By a comprehensive review of scientific publications on these two matters, together with a survey responded by over 360 patients across Europe, this report aims to highlight the current challenges that lung cancer community is facing in terms of delivering fasters and more precise diagnosis, as well as to analyse the current implementation of screening programmes across Europe. It also focuses on the current knowledge and education needs of patients regarding diagnosis and screening.
By MEPs Against Cancer (MAC) interest group
The MEPs Against Cancer (MAC) interest group at the European Parliament is pleased to announce new leadership elected for the 2019-24 parliamentary legislature. MEPs Prof. Véronique Trillet-Lenoir (RE, France) and Mr. Loucas Fourlas (EPP, Cyprus) are the new Chairs of the MAC Group. MEPs Mr. Rory Palmer (S&D, United Kingdom) and Dr. Petra De Sutter (Greens/EFA, Belgium) are the new Vice-Chairs. Together with the secretarial support from the Association of European Cancer Leagues (ECL), they will lead the group which currently consists of 137 members.
The report is intended to provide a cohesive overview of the current state of play of data-driven technologies within the health and care system. We hope that it will make clear where in the system AI technologies can be utilised and the policy work that is, and will need to be done, to ensure this utilisation is done in a safe, effective and ethically acceptable manner.
Update: the summary report of the hearing and the slides of the presentation delivered at the meeting are now available
The hearing is open to institutions and professional bodies, representatives of Member States, non-governmental organisations, academics, EU institutions and relevant stakeholders active in health related issues that wish to share views on the draft Opinion. As the number of seats available is limited to 60, final participation will be confirmed based on a registration process. The hearing will be web streamed.
Live event at the European Parliament kindly supported by Irena Joveva MEP and the Renew Europe political group.
Member organisations of the European CanCer Organisation (ECCO) such as the European Society of Breast Cancer Specialists (EUSOMA), the European Society of Surgical Oncology (ESSO), the European Organisation for Research and Treatment of Cancer (EORTC), the Organisation of European Cancer Institutes (OECI) and others will seek to provide answers to this question. In so doing, policy recommendations will be illuminated to assist the developing EU Cancer Mission and European Beating Cancer Plan in fully utilising data as a tool for improving quality of cancer care in Europe.
For discussion at the meeting of the Working Party on Social Questions of 7 November 2019.
On the occasion of Breast Cancer Awareness Month, the JRC presents a plethora of new, evidence-based recommendations for breast cancer healthcare on its new, enhanced, user-friendly website.
The new guidelines cover the following issues: How to invite and inform women about screening, Staging of breast cancer, Mammography readers and Communication training for the staff.
A summary of the exchange of views is now available